These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 7775634)

  • 1. Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WR; Shalet SM
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1869-75. PubMed ID: 7775634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
    Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WH; Holly JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):209-16. PubMed ID: 9135704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
    Malhotra A; Poon E; Tse WY; Pringle PJ; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):393-8. PubMed ID: 8319371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
    Wu FC; Brown DC; Butler GE; Stirling HF; Kelnar CJ
    J Clin Endocrinol Metab; 1993 Jan; 76(1):26-31. PubMed ID: 8421096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of changing gonadotropin-releasing hormone pulse frequency on puberty.
    Bridges NA; Hindmarsh PC; Matthews DR; Brook CG
    J Clin Endocrinol Metab; 1994 Sep; 79(3):841-7. PubMed ID: 8077371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of gonadotropin, testosterone, and inhibin secretion in normal boys through puberty based on overnight serial sampling.
    Manasco PK; Umbach DM; Muly SM; Godwin DC; Negro-Vilar A; Culler MD; Underwood LE
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2046-52. PubMed ID: 7608253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of luteinizing hormone-beta gene polymorphism in the onset and progression of puberty in healthy boys.
    Raivio T; Huhtaniemi I; Anttila R; Siimes MA; Hagenäs L; Nilsson C; Pettersson K; Dunkel L
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3278-82. PubMed ID: 8784083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.
    Ehrmann DA; Rosenfield RL; Cuttler L; Burstein S; Cara JF; Levitsky LL
    J Clin Endocrinol Metab; 1989 Nov; 69(5):963-7. PubMed ID: 2529266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
    Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
    J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge.
    Ghai K; Rosenfield RL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1336-40. PubMed ID: 8200935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys.
    Albertsson-Wikland K; Rosberg S; Lannering B; Dunkel L; Selstam G; Norjavaara E
    J Clin Endocrinol Metab; 1997 Feb; 82(2):541-9. PubMed ID: 9024251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
    Stanhope R; Hindmarsh P; Pringle PJ; Holownia P; Honour J; Brook CG
    Pediatrician; 1987; 14(3):183-8. PubMed ID: 3453497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the short stature due to pubertal delay in boys.
    Adan L; Souberbielle JC; Brauner R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.
    Ghai K; Cara JF; Rosenfield RL
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2980-6. PubMed ID: 7559884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.
    Soliman AT; Nasr I; Thabet A; Rizk MM; El Matary W
    Metabolism; 2005 Jan; 54(1):15-23. PubMed ID: 15562375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
    Butler GE; Sellar RE; Walker RF; Hendry M; Kelnar CJ; Wu FC
    J Clin Endocrinol Metab; 1992 Jul; 75(1):37-44. PubMed ID: 1619029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement.
    Veldhuis JD; Metzger DL; Martha PM; Mauras N; Kerrigan JR; Keenan B; Rogol AD; Pincus SM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3414-20. PubMed ID: 9329378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
    Clayton PE; Shalet SM; Price DA; Addison GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):123-30. PubMed ID: 3248354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.